The Graham Fulford Charitable Trust

The Graham Fulford Charitable Trust (GFCT) was set up by Graham Fulford to promote awareness of prostate cancer following the diagnosis of a close friend who died at the age of 58 and a close family member who died in 2007 from prostate cancer after a valiant fight. GFCT is dedicated to supporting health tests for early diagnosis, particularly focusing on prostate cancer awareness and testing. The organization aims to improve early detection of prostate cancer through various initiatives, including public testing events and partnerships with healthcare providers. The trust has been involved in testing thousands of men for prostate awareness, leading to the identification of many cancers that may not have been discovered otherwise. They offer testing events across the UK for various health conditions, including prostate cancer, diabetes, and menopause. The Trust is also involved in research aimed at implementing a National Prostate Cancer Screening Programme in the UK, and they strive to raise awareness about the importance of early diagnosis through public events and educational resources. The TRANSFORM research project, a £42 million trial, aims to find the best way to screen men for prostate cancer, ensuring that all men at risk are invited for regular tests to detect aggressive cancers in time for treatment. The trust collaborates with various partners, including the NHS and philanthropic organizations, to enhance prostate cancer awareness and treatment options. GFCT supports health tests for early diagnosis, particularly focusing on PSA testing for prostate cancer. The organization collects data through consent forms during PSA tests, which are processed to provide results and follow-up communications to individuals. They ensure data privacy in compliance with GDPR, maintaining the confidentiality and security of personal information while facilitating health testing events and providing statistical analysis for research purposes.